Penumbra, Inc Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
Penumbra, Inc (PEN) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-25.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2026-02-25
- Penumbra, Inc share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2025 was $0.00.
- Penumbra, Inc share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $0.00.
- Penumbra, Inc share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- Penumbra, Inc share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $197.74, a 669.12% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-25 | ||
| 2024-12-31 | $0.00 10-K · filed 2025-02-18 | ||
| 2023-12-31 | $0.00 10-K · filed 2024-02-22 | ||
| 2022-12-31 | $197.74 10-K · filed 2023-02-23 | ||
| 2022-09-30 | $197.74 10-Q · filed 2022-11-03 | ||
| 2022-06-30 | $197.74 10-Q · filed 2022-08-05 | ||
| 2021-12-31 | $25.71 10-K · filed 2022-02-22 | ||
| 2020-12-31 | $0.00 10-K · filed 2021-02-23 | ||
| 2019-12-31 | $158.30 10-K · filed 2020-02-26 | ||
| 2015-12-31 | $21.47 10-K · filed 2016-03-08 | ||
| 2015-09-30 | $21.47 10-Q · filed 2015-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |